ArticleCancer science2019

Safety and effectiveness of alectinib in a real-world surveillance study in patients with ALK-positive non-small-cell lung cancer in Japan.

Noriyuki Masuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.